Arthritis (juvenile idiopathic, systemic) - tocilizumab: response to consultee, commentator and public comments on the appraisal consultation document (ACD)
|
Arthritis (juvenile idiopathic, systemic) - tocilizumab: response to consultee, commentator and public comments on the appraisal consultation document (ACD)
27 October 2011 (261.86 Kb 16 sec) |
This page was last updated: 26 October 2011